Pharmagreen Biotech Inc (PHBI)
0.0012
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Pharmagreen Biotech Total Liabilities (Quarterly): 2.291M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 2.291M |
| March 31, 2023 | 2.151M |
| December 31, 2022 | 2.009M |
| September 30, 2022 | 2.032M |
| June 30, 2022 | 2.129M |
| March 31, 2022 | 2.601M |
| December 31, 2021 | 1.942M |
| September 30, 2021 | 2.066M |
| June 30, 2021 | 1.860M |
| Date | Value |
|---|---|
| March 31, 2021 | 1.884M |
| December 31, 2020 | 2.037M |
| September 30, 2020 | 3.200M |
| June 30, 2020 | 3.057M |
| March 31, 2020 | 1.808M |
| December 31, 2019 | 1.659M |
| September 30, 2019 | 1.465M |
| June 30, 2019 | 1.319M |
| September 30, 2018 | 1.837M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.319M
Minimum
Jun 2019
3.200M
Maximum
Sep 2020
2.089M
Average
2.032M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 11.36M |
| Perspective Therapeutics Inc | 48.40M |
| Protalix BioTherapeutics Inc | 60.04M |
| Electromed Inc | 6.357M |
| Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.1403M |
| Shareholders Equity (Quarterly) | -2.104M |
| Debt to Equity Ratio | -0.1898 |
| Current Ratio | 0.0237 |